nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—Parkinson's disease	0.48	0.583	CbGaD
Reboxetine—ABCB1—Parkinson's disease	0.343	0.417	CbGaD
Reboxetine—SLC6A2—locus ceruleus—Parkinson's disease	0.0119	0.152	CbGeAlD
Reboxetine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00943	0.12	CbGeAlD
Reboxetine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00678	0.0863	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00634	0.0807	CbGeAlD
Reboxetine—SLC6A2—nerve—Parkinson's disease	0.00357	0.0454	CbGeAlD
Reboxetine—SLC6A4—hindbrain—Parkinson's disease	0.00303	0.0386	CbGeAlD
Reboxetine—HTR2C—brainstem—Parkinson's disease	0.00183	0.0234	CbGeAlD
Reboxetine—HTR2C—forebrain—Parkinson's disease	0.00177	0.0225	CbGeAlD
Reboxetine—SLC6A4—brainstem—Parkinson's disease	0.00174	0.0221	CbGeAlD
Reboxetine—SLC6A4—forebrain—Parkinson's disease	0.00168	0.0214	CbGeAlD
Reboxetine—SLC6A2—brainstem—Parkinson's disease	0.00153	0.0195	CbGeAlD
Reboxetine—Diphenylpyraline—SLC6A3—Parkinson's disease	0.0015	0.272	CrCbGaD
Reboxetine—SLC6A2—forebrain—Parkinson's disease	0.00148	0.0188	CbGeAlD
Reboxetine—CYP2D6—hindbrain—Parkinson's disease	0.00146	0.0186	CbGeAlD
Reboxetine—HTR2C—medulla oblongata—Parkinson's disease	0.00128	0.0163	CbGeAlD
Reboxetine—HTR2C—midbrain—Parkinson's disease	0.00117	0.0149	CbGeAlD
Reboxetine—Benzatropine—SLC6A3—Parkinson's disease	0.00115	0.209	CrCbGaD
Reboxetine—HTR2C—spinal cord—Parkinson's disease	0.00114	0.0145	CbGeAlD
Reboxetine—SLC6A4—midbrain—Parkinson's disease	0.00111	0.0141	CbGeAlD
Reboxetine—SLC6A4—spinal cord—Parkinson's disease	0.00108	0.0138	CbGeAlD
Reboxetine—SLC6A2—medulla oblongata—Parkinson's disease	0.00107	0.0136	CbGeAlD
Reboxetine—HTR2C—head—Parkinson's disease	0.00101	0.0129	CbGeAlD
Reboxetine—HTR2C—nervous system—Parkinson's disease	0.000961	0.0122	CbGeAlD
Reboxetine—SLC6A4—head—Parkinson's disease	0.000961	0.0122	CbGeAlD
Reboxetine—HTR2C—central nervous system—Parkinson's disease	0.000925	0.0118	CbGeAlD
Reboxetine—SLC6A4—nervous system—Parkinson's disease	0.000911	0.0116	CbGeAlD
Reboxetine—SLC6A4—central nervous system—Parkinson's disease	0.000877	0.0112	CbGeAlD
Reboxetine—SLC6A2—head—Parkinson's disease	0.000846	0.0108	CbGeAlD
Reboxetine—CYP2D6—brainstem—Parkinson's disease	0.000838	0.0107	CbGeAlD
Reboxetine—CYP2D6—forebrain—Parkinson's disease	0.000809	0.0103	CbGeAlD
Reboxetine—SLC6A2—nervous system—Parkinson's disease	0.000802	0.0102	CbGeAlD
Reboxetine—SLC6A2—central nervous system—Parkinson's disease	0.000772	0.00983	CbGeAlD
Reboxetine—HTR2C—brain—Parkinson's disease	0.000734	0.00935	CbGeAlD
Reboxetine—Atomoxetine—SLC6A3—Parkinson's disease	0.00073	0.133	CrCbGaD
Reboxetine—SLC6A4—brain—Parkinson's disease	0.000696	0.00887	CbGeAlD
Reboxetine—ABCB1—embryo—Parkinson's disease	0.000658	0.00838	CbGeAlD
Reboxetine—SLC6A2—brain—Parkinson's disease	0.000613	0.00781	CbGeAlD
Reboxetine—Benzatropine—CYP2D6—Parkinson's disease	0.000603	0.11	CrCbGaD
Reboxetine—ABCB1—forebrain—Parkinson's disease	0.000582	0.00741	CbGeAlD
Reboxetine—ABCB1—cardiovascular system—Parkinson's disease	0.000492	0.00627	CbGeAlD
Reboxetine—CYP2D6—head—Parkinson's disease	0.000463	0.0059	CbGeAlD
Reboxetine—CYP3A4—nervous system—Parkinson's disease	0.000446	0.00568	CbGeAlD
Reboxetine—CYP2D6—nervous system—Parkinson's disease	0.000439	0.00559	CbGeAlD
Reboxetine—CYP3A4—central nervous system—Parkinson's disease	0.00043	0.00547	CbGeAlD
Reboxetine—CYP2D6—central nervous system—Parkinson's disease	0.000423	0.00538	CbGeAlD
Reboxetine—ABCB1—medulla oblongata—Parkinson's disease	0.00042	0.00535	CbGeAlD
Reboxetine—Atomoxetine—HTR2A—Parkinson's disease	0.00042	0.0765	CrCbGaD
Reboxetine—CYP2D6—cerebellum—Parkinson's disease	0.000413	0.00526	CbGeAlD
Reboxetine—Orphenadrine—CYP2E1—Parkinson's disease	0.000399	0.0728	CrCbGaD
Reboxetine—ABCB1—midbrain—Parkinson's disease	0.000384	0.00489	CbGeAlD
Reboxetine—Atomoxetine—CYP2D6—Parkinson's disease	0.000384	0.0699	CrCbGaD
Reboxetine—ABCB1—spinal cord—Parkinson's disease	0.000375	0.00477	CbGeAlD
Reboxetine—CYP2D6—brain—Parkinson's disease	0.000336	0.00427	CbGeAlD
Reboxetine—ABCB1—head—Parkinson's disease	0.000333	0.00424	CbGeAlD
Reboxetine—ABCB1—nervous system—Parkinson's disease	0.000316	0.00402	CbGeAlD
Reboxetine—Diphenhydramine—CYP2D6—Parkinson's disease	0.00031	0.0565	CrCbGaD
Reboxetine—ABCB1—central nervous system—Parkinson's disease	0.000304	0.00387	CbGeAlD
Reboxetine—ABCB1—cerebellum—Parkinson's disease	0.000297	0.00379	CbGeAlD
Reboxetine—ABCB1—brain—Parkinson's disease	0.000241	0.00307	CbGeAlD
Reboxetine—HTR2C—GPCR ligand binding—PENK—Parkinson's disease	0.00017	0.00182	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000169	0.00182	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000168	0.00181	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000167	0.00179	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000165	0.00177	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000163	0.00175	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000161	0.00173	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000161	0.00173	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000159	0.00171	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000157	0.00169	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000156	0.00167	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—PDYN—Parkinson's disease	0.000155	0.00167	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000154	0.00165	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000153	0.00164	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000151	0.00162	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000149	0.0016	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—GRM5—Parkinson's disease	0.000144	0.00155	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000143	0.00154	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—EDN1—Parkinson's disease	0.000143	0.00154	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00014	0.0015	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000138	0.00148	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000138	0.00148	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000138	0.00148	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000138	0.00148	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DGKQ—Parkinson's disease	0.000135	0.00145	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GPR37—Parkinson's disease	0.000135	0.00145	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000135	0.00145	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000134	0.00144	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000134	0.00144	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000131	0.0014	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000128	0.00137	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000126	0.00136	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.000125	0.00134	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000124	0.00133	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000124	0.00133	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000123	0.00133	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000123	0.00133	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000123	0.00132	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000118	0.00127	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000118	0.00127	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GRK5—Parkinson's disease	0.000113	0.00121	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.000112	0.0012	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000111	0.0012	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000111	0.0012	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000111	0.00119	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000109	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR1A—Parkinson's disease	0.000106	0.00114	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TAC1—Parkinson's disease	0.000105	0.00113	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000104	0.00112	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD1—Parkinson's disease	0.000103	0.0011	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000103	0.0011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GRK5—Parkinson's disease	0.000102	0.0011	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000101	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GRM4—Parkinson's disease	0.000101	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD3—Parkinson's disease	9.95e-05	0.00107	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	9.86e-05	0.00106	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.66e-05	0.00104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VPS35—Parkinson's disease	9.63e-05	0.00104	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PENK—Parkinson's disease	9.58e-05	0.00103	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.46e-05	0.00102	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—MAPK8—Parkinson's disease	9.25e-05	0.000994	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GRM4—Parkinson's disease	9.18e-05	0.000987	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD2—Parkinson's disease	9e-05	0.000967	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR7—Parkinson's disease	9e-05	0.000967	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.96e-05	0.000964	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.79e-05	0.000945	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PDYN—Parkinson's disease	8.76e-05	0.000942	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PENK—Parkinson's disease	8.7e-05	0.000936	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	8.5e-05	0.000914	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	8.46e-05	0.000909	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.44e-05	0.000908	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	8.44e-05	0.000907	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	8.38e-05	0.000901	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	8.34e-05	0.000897	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.28e-05	0.00089	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GRM5—Parkinson's disease	8.15e-05	0.000876	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	8.07e-05	0.000867	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	8.06e-05	0.000867	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	8.04e-05	0.000865	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DGKQ—Parkinson's disease	7.98e-05	0.000858	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GPR37—Parkinson's disease	7.98e-05	0.000858	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PDYN—Parkinson's disease	7.96e-05	0.000856	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.94e-05	0.000854	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.77e-05	0.000836	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.67e-05	0.000824	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GRM5—Parkinson's disease	7.4e-05	0.000796	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.34e-05	0.000789	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	7.33e-05	0.000788	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PPP1R1B—Parkinson's disease	7.3e-05	0.000784	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.23e-05	0.000778	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.23e-05	0.000777	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—EDN1—Parkinson's disease	7.2e-05	0.000775	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.05e-05	0.000758	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.04e-05	0.000757	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.93e-05	0.000745	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.7e-05	0.000721	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.61e-05	0.000711	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RIT2—Parkinson's disease	6.38e-05	0.000686	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—Parkinson's disease	6.3e-05	0.000678	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADORA2A—Parkinson's disease	6.29e-05	0.000676	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRK5—Parkinson's disease	6.05e-05	0.00065	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1A—Parkinson's disease	6.01e-05	0.000646	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TAC1—Parkinson's disease	5.92e-05	0.000637	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	5.91e-05	0.000635	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.91e-05	0.000635	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.85e-05	0.000629	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.85e-05	0.000629	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ND3—Parkinson's disease	5.85e-05	0.000629	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD1—Parkinson's disease	5.81e-05	0.000624	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD3—Parkinson's disease	5.62e-05	0.000605	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.56e-05	0.000597	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.53e-05	0.000595	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.52e-05	0.000593	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ND3—Parkinson's disease	5.51e-05	0.000592	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.51e-05	0.000592	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—OMD—Parkinson's disease	5.5e-05	0.000591	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.5e-05	0.000591	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.48e-05	0.000589	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1A—Parkinson's disease	5.46e-05	0.000587	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.45e-05	0.000586	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.43e-05	0.000584	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRM4—Parkinson's disease	5.42e-05	0.000583	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TAC1—Parkinson's disease	5.38e-05	0.000578	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD1—Parkinson's disease	5.27e-05	0.000567	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.25e-05	0.000565	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.21e-05	0.00056	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.18e-05	0.000557	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—OMD—Parkinson's disease	5.18e-05	0.000557	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PENK—Parkinson's disease	5.14e-05	0.000553	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAG—Parkinson's disease	5.14e-05	0.000553	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD3—Parkinson's disease	5.11e-05	0.000549	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR7—Parkinson's disease	5.09e-05	0.000547	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD2—Parkinson's disease	5.09e-05	0.000547	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.08e-05	0.000546	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.01e-05	0.000539	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCH1—Parkinson's disease	4.97e-05	0.000535	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.91e-05	0.000528	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	4.77e-05	0.000513	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	4.7e-05	0.000506	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.69e-05	0.000504	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	4.62e-05	0.000496	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	4.62e-05	0.000496	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GBA—Parkinson's disease	4.43e-05	0.000476	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DBH—Parkinson's disease	4.43e-05	0.000476	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—FBP1—Parkinson's disease	4.43e-05	0.000476	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	4.42e-05	0.000475	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	4.37e-05	0.00047	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000449	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000449	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000449	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	4.07e-05	0.000438	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.97e-05	0.000427	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.88e-05	0.000417	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.87e-05	0.000416	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	3.83e-05	0.000412	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.72e-05	0.0004	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	3.72e-05	0.0004	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	3.7e-05	0.000397	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.65e-05	0.000392	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.6e-05	0.000387	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.6e-05	0.000387	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	3.56e-05	0.000383	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	3.43e-05	0.000369	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.39e-05	0.000364	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—OMD—Parkinson's disease	3.39e-05	0.000364	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DDC—Parkinson's disease	3.25e-05	0.00035	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	3.24e-05	0.000349	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	3.23e-05	0.000348	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.23e-05	0.000347	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	3.22e-05	0.000347	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.21e-05	0.000345	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	3.18e-05	0.000341	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	3.11e-05	0.000335	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.07e-05	0.00033	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.07e-05	0.00033	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.06e-05	0.000329	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	3.02e-05	0.000324	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.89e-05	0.000311	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.89e-05	0.00031	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	2.82e-05	0.000303	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.77e-05	0.000297	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.74e-05	0.000294	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.73e-05	0.000294	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.73e-05	0.000294	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.73e-05	0.000294	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	2.73e-05	0.000293	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	2.73e-05	0.000293	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.00028	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000277	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	2.29e-05	0.000246	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	2.21e-05	0.000238	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	2.18e-05	0.000235	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.03e-05	0.000219	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	2.01e-05	0.000216	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DDC—Parkinson's disease	2e-05	0.000215	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CTGF—Parkinson's disease	2e-05	0.000215	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	1.91e-05	0.000205	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.89e-05	0.000203	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.000202	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.86e-05	0.0002	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.84e-05	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TH—Parkinson's disease	1.81e-05	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	1.78e-05	0.000191	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	0.000189	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.74e-05	0.000187	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.73e-05	0.000186	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TH—Parkinson's disease	1.71e-05	0.000184	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.7e-05	0.000183	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.69e-05	0.000181	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000176	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—COMT—Parkinson's disease	1.54e-05	0.000166	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.53e-05	0.000165	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.53e-05	0.000165	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—Parkinson's disease	1.52e-05	0.000163	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.51e-05	0.000163	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.45e-05	0.000156	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.000156	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.44e-05	0.000155	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000153	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.41e-05	0.000152	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.37e-05	0.000147	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.35e-05	0.000145	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.33e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.27e-05	0.000137	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.25e-05	0.000135	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.25e-05	0.000134	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.23e-05	0.000132	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.17e-05	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—Parkinson's disease	1.16e-05	0.000125	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	0.000123	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.13e-05	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	1.13e-05	0.000121	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	1.12e-05	0.000121	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TH—Parkinson's disease	1.12e-05	0.00012	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.09e-05	0.000118	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.07e-05	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.04e-05	0.000112	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—Parkinson's disease	9.91e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COMT—Parkinson's disease	9.5e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.46e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.43e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—Parkinson's disease	9.34e-06	0.0001	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.33e-06	0.0001	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.95e-06	9.62e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.69e-06	9.34e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.32e-06	8.95e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.68e-06	8.26e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—Parkinson's disease	7.15e-06	7.69e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	6.63e-06	7.13e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—Parkinson's disease	6.11e-06	6.57e-05	CbGpPWpGaD
